The TPP, IP and the Australasian healthcare industry - what's at stake?
there are fears that the TPP may reduce access to affordable medicines throughout the region party to the agreement. Additionally, many worry that the TPP may not be flexible enough to accommodate existing non-discriminatory drug reimbursement programs and the diverse health systems of the member countries. Full Story »
Posted by Dwight Rousu
Retrieving Comments



